Furthermore, several studies have shown that adiponectin or adiponectin receptor agonists (AdipoRon) can regualte the polarization and activity of microglia, reduce the inflammatory responses, and improve the neuropathology in an AD mouse model (29, 30). Here, ADIPOQ is linked to Alzheimer disease.